Variation in the level of fetal hemoglobin (HbF) accounts for much of the clinical heterogeneity observed in patients with sickle cell disease (SCD). The HbF level has emerged as an important prognostic factor in both sickle cell pain and mortality, and a % HbF of 10-20% has been suggested as a thre
β¦ LIBER β¦
Fetal outcome and childhood mortality in offspring of mothers with sickle cell trait and disease
β Scribed by R. S. Balgir; B. P. Dash; R. K. Das
- Publisher
- Springer-Verlag
- Year
- 1997
- Tongue
- English
- Weight
- 384 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0019-5456
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Quantitative analysis of erythrocytes co
β
Marcus, Stacy J.; Kinney, Thomas R.; Schultz, William H.; O'Branski, Erin E.; Wa
π
Article
π
1997
π
John Wiley and Sons
π
English
β 110 KB
π 2 views
Protective role of hemoglobin and fetal
β
Jeffrey Lebensburger; Stephen M. Johnson; David J. Askenazi; Nigel L. Rozario; T
π
Article
π
2011
π
John Wiley and Sons
π
English
β 75 KB
π 2 views
Morbidity and mortality in chronically t
β
Ellen B. Fung; Paul Harmatz; Meredith Milet; Samir K. Ballas; Laura De Castro; W
π
Article
π
2007
π
John Wiley and Sons
π
English
β 190 KB
π 2 views
## Abstract A natural history study was conducted in 142 Thalassemic (Thal), 199 transfused Sickle Cell Disease (TxβSCD, __n__ = 199), and 64 nonβTxβSCD subjects to describe the frequency of ironβrelated morbidity and mortality. Subjects recruited from 31 centers in the US, Canada or the UK were si
Effects of RANTES and MBL2 gene polymorp
β
Omer Placide Dossou-Yovo; Isabelle Zaccaria; Malika Benkerrou; Michelle Haucheco
π
Article
π
2009
π
John Wiley and Sons
π
English
β 391 KB
π 2 views